US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 48.030
  • +0.490+1.03%
Close Dec 26 16:00 ET
  • 48.030
  • 0.0000.00%
Pre 04:43 ET
6.11BMarket Cap15.90P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
34.28%290.08M
4.67%231.35M
20.81%195.88M
25.62%829.25M
26.75%230.04M
3.38%216.03M
45.07%221.04M
38.25%162.14M
48.91%660.12M
77.93%181.5M
Operating revenue
34.28%290.08M
4.67%231.35M
20.81%195.88M
25.62%829.25M
26.75%230.04M
3.38%216.03M
45.07%221.04M
38.25%162.14M
48.91%660.12M
77.93%181.5M
Cost of revenue
-9.84%49.43M
-20.90%39.61M
-19.45%28.33M
38.09%192.36M
24.16%52.3M
15.86%54.82M
47.51%50.07M
120.89%35.17M
71.11%139.3M
95.12%42.12M
Gross profit
49.28%240.66M
12.15%191.75M
31.96%167.55M
22.29%636.89M
27.53%177.74M
-0.28%161.21M
44.37%170.97M
25.27%126.97M
43.91%520.81M
73.32%139.38M
Operating expense
6.21%77.46M
-2.61%74.51M
-1.59%72.01M
18.18%299.32M
18.25%76.71M
-6.93%72.93M
-9.31%76.51M
184.86%73.17M
194.53%253.28M
171.61%64.87M
Selling and administrative expenses
16.93%41.24M
-8.31%35.71M
-5.95%35.13M
3.94%149.18M
-0.37%37.61M
2.33%35.27M
-32.24%38.95M
170.04%37.36M
185.21%143.53M
174.06%37.75M
Research and development costs
6.56%18.46M
6.65%21.04M
6.30%19.11M
14.65%76.36M
-5.45%21.34M
3.69%17.32M
27.41%19.73M
51.68%17.98M
86.72%66.61M
123.25%22.57M
Depreciation amortization depletion
-12.68%17.76M
-0.41%17.76M
-0.40%17.76M
70.98%73.77M
290.20%17.76M
-25.20%20.34M
56.41%17.84M
--17.84M
--43.15M
--4.55M
-Depreciation and amortization
-12.68%17.76M
-0.41%17.76M
-0.40%17.76M
70.98%73.77M
290.20%17.76M
-25.20%20.34M
56.41%17.84M
--17.84M
--43.15M
--4.55M
Operating profit
84.87%163.2M
24.11%117.24M
77.58%95.54M
26.18%337.57M
35.60%101.04M
5.99%88.28M
177.33%94.46M
-28.90%53.8M
-3.03%267.53M
31.80%74.51M
Net non-operating interest income expense
-0.42%-4.52M
-0.67%-4.52M
0.79%-4.51M
-10.71%-18.76M
-14.22%-5.22M
40.05%-4.51M
-44.78%-4.49M
-158.27%-4.54M
-125.18%-16.95M
-122.38%-4.57M
Non-operating interest expense
0.42%4.52M
0.67%4.52M
-0.79%4.51M
10.71%18.76M
14.22%5.22M
-40.05%4.51M
44.78%4.49M
158.27%4.54M
125.18%16.95M
122.38%4.57M
Other net income (expense)
-64.01%6.47M
57.64%5.03M
67.61%4.99M
1,871.73%29.52M
529.11%5.36M
968.47%17.99M
437.78%3.19M
498.19%2.98M
91.61%-1.67M
157.40%852K
Gain on sale of security
35.27%6.47M
57.64%5.03M
67.61%4.99M
1,459.94%16.32M
529.11%5.36M
646.65%4.79M
437.78%3.19M
498.19%2.98M
-5.08%1.05M
157.40%852K
Special income (charges)
--0
----
----
586.73%13.2M
--0
586.73%13.2M
----
----
87.06%-2.71M
--0
-Less：Restructuring and merger&acquisition
--0
----
----
---13.2M
--0
---13.2M
----
----
--0
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
-87.06%2.71M
--0
Income before tax
62.29%165.15M
26.39%117.74M
83.83%96.03M
39.94%348.33M
42.92%101.18M
38.06%101.76M
210.41%93.16M
-29.80%52.24M
0.16%248.92M
29.16%70.79M
Income tax
41.22%28.14M
33.13%24.5M
52.14%19.21M
42.63%66.74M
20.61%15.79M
65.02%19.92M
151.19%18.4M
-11.73%12.62M
130.34%46.79M
209.44%13.09M
Net income
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Net income continuous Operations
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Minority interest income
Net income attributable to the parent company
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Basic earnings per share
74.19%1.08
28.07%0.73
110.34%0.61
43.92%2.13
51.16%0.65
37.78%0.62
256.25%0.57
-34.09%0.29
-48.25%1.48
-10.42%0.43
Diluted earnings per share
72.13%1.05
28.57%0.72
106.90%0.6
45.83%2.1
54.76%0.65
38.64%0.61
250.00%0.56
-32.56%0.29
-47.45%1.44
-8.70%0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 34.28%290.08M4.67%231.35M20.81%195.88M25.62%829.25M26.75%230.04M3.38%216.03M45.07%221.04M38.25%162.14M48.91%660.12M77.93%181.5M
Operating revenue 34.28%290.08M4.67%231.35M20.81%195.88M25.62%829.25M26.75%230.04M3.38%216.03M45.07%221.04M38.25%162.14M48.91%660.12M77.93%181.5M
Cost of revenue -9.84%49.43M-20.90%39.61M-19.45%28.33M38.09%192.36M24.16%52.3M15.86%54.82M47.51%50.07M120.89%35.17M71.11%139.3M95.12%42.12M
Gross profit 49.28%240.66M12.15%191.75M31.96%167.55M22.29%636.89M27.53%177.74M-0.28%161.21M44.37%170.97M25.27%126.97M43.91%520.81M73.32%139.38M
Operating expense 6.21%77.46M-2.61%74.51M-1.59%72.01M18.18%299.32M18.25%76.71M-6.93%72.93M-9.31%76.51M184.86%73.17M194.53%253.28M171.61%64.87M
Selling and administrative expenses 16.93%41.24M-8.31%35.71M-5.95%35.13M3.94%149.18M-0.37%37.61M2.33%35.27M-32.24%38.95M170.04%37.36M185.21%143.53M174.06%37.75M
Research and development costs 6.56%18.46M6.65%21.04M6.30%19.11M14.65%76.36M-5.45%21.34M3.69%17.32M27.41%19.73M51.68%17.98M86.72%66.61M123.25%22.57M
Depreciation amortization depletion -12.68%17.76M-0.41%17.76M-0.40%17.76M70.98%73.77M290.20%17.76M-25.20%20.34M56.41%17.84M--17.84M--43.15M--4.55M
-Depreciation and amortization -12.68%17.76M-0.41%17.76M-0.40%17.76M70.98%73.77M290.20%17.76M-25.20%20.34M56.41%17.84M--17.84M--43.15M--4.55M
Operating profit 84.87%163.2M24.11%117.24M77.58%95.54M26.18%337.57M35.60%101.04M5.99%88.28M177.33%94.46M-28.90%53.8M-3.03%267.53M31.80%74.51M
Net non-operating interest income expense -0.42%-4.52M-0.67%-4.52M0.79%-4.51M-10.71%-18.76M-14.22%-5.22M40.05%-4.51M-44.78%-4.49M-158.27%-4.54M-125.18%-16.95M-122.38%-4.57M
Non-operating interest expense 0.42%4.52M0.67%4.52M-0.79%4.51M10.71%18.76M14.22%5.22M-40.05%4.51M44.78%4.49M158.27%4.54M125.18%16.95M122.38%4.57M
Other net income (expense) -64.01%6.47M57.64%5.03M67.61%4.99M1,871.73%29.52M529.11%5.36M968.47%17.99M437.78%3.19M498.19%2.98M91.61%-1.67M157.40%852K
Gain on sale of security 35.27%6.47M57.64%5.03M67.61%4.99M1,459.94%16.32M529.11%5.36M646.65%4.79M437.78%3.19M498.19%2.98M-5.08%1.05M157.40%852K
Special income (charges) --0--------586.73%13.2M--0586.73%13.2M--------87.06%-2.71M--0
-Less：Restructuring and merger&acquisition --0-----------13.2M--0---13.2M----------0--0
-Less:Other special charges ---------------------------------87.06%2.71M--0
Income before tax 62.29%165.15M26.39%117.74M83.83%96.03M39.94%348.33M42.92%101.18M38.06%101.76M210.41%93.16M-29.80%52.24M0.16%248.92M29.16%70.79M
Income tax 41.22%28.14M33.13%24.5M52.14%19.21M42.63%66.74M20.61%15.79M65.02%19.92M151.19%18.4M-11.73%12.62M130.34%46.79M209.44%13.09M
Net income 67.42%137.01M24.74%93.25M93.92%76.82M39.31%281.59M47.98%85.39M32.78%81.84M229.53%74.75M-34.09%39.62M-49.81%202.13M-13.58%57.7M
Net income continuous Operations 67.42%137.01M24.74%93.25M93.92%76.82M39.31%281.59M47.98%85.39M32.78%81.84M229.53%74.75M-34.09%39.62M-49.81%202.13M-13.58%57.7M
Minority interest income
Net income attributable to the parent company 67.42%137.01M24.74%93.25M93.92%76.82M39.31%281.59M47.98%85.39M32.78%81.84M229.53%74.75M-34.09%39.62M-49.81%202.13M-13.58%57.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 67.42%137.01M24.74%93.25M93.92%76.82M39.31%281.59M47.98%85.39M32.78%81.84M229.53%74.75M-34.09%39.62M-49.81%202.13M-13.58%57.7M
Basic earnings per share 74.19%1.0828.07%0.73110.34%0.6143.92%2.1351.16%0.6537.78%0.62256.25%0.57-34.09%0.29-48.25%1.48-10.42%0.43
Diluted earnings per share 72.13%1.0528.57%0.72106.90%0.645.83%2.154.76%0.6538.64%0.61250.00%0.56-32.56%0.29-47.45%1.44-8.70%0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+2.37%
Alibaba
BABA
+0.65%
Adobe
ADBE
+0.50%
Apple
AAPL
+0.32%
Cisco
CSCO
+0.22%

Unlock the Full List